Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Molecular and Chemical Neuropathology|May 18, 1999
Decreased serotonin2A receptors in Brodmann's area 9 from schizophrenic subjects. A pathological or pharmacological phenomenon?B Dean, W Hayes, C Hill, et al.
Neuroscience|September 29, 2000
Reduced number of neurons in the hippocampus and the cerebellum in the postnatal guinea-pig following intrauterine growth-restrictionC Mallard, M Loeliger, D Copolov, et al.
The Australian and New Zealand Journal of Psychiatry|August 26, 1998
The clinical use of plasma clozapine levelsR Bell, A McLaren, J Galanos, et al.
European Journal of Pharmacology|August 19, 1983
Behavioural effect of adrenalectomy: reversal by glucocorticoids or [D-Ala2,Met5]enkephalinamideD Jefferys, D Copolov, D Irby, et al.
Neuroreport|February 24, 2001
LIF is more potent than BDNF in promoting neurite outgrowth of mammalian auditory neurons in vitroL N Gillespie, G M Clark, P F Bartlett, et al.
Life Sciences|June 3, 1999
The binding of [3H]AF-DX 384 is reduced in the caudate-putamen of subjects with schizophreniaJ M Crook, B Dean, G Pavey, et al.
Molecular Endocrinology (Baltimore, Md.)|February 11, 1999
D5 dopamine receptors mediate estrogen-induced stimulation of hypothalamic atrial natriuretic factor neuronsD Lee, P Dong, D Copolov, et al.
European Journal of Pharmacology|July 22, 1998
Clozapine and olanzapine treatment decreases rat cortical and limbic GABA(A) receptorsD Farnbach-Pralong, R Bradbury, D Copolov, et al.
Neuroscience|April 20, 2001
Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis useB Dean, S Sundram, R Bradbury, et al.
The Australian and New Zealand Journal of Psychiatry|April 1, 1997
Ocular abnormalities in chronic schizophrenia: clinical implicationsD Smith, C Pantelis, J McGrath, et al.
Pageof 6